| Literature DB >> 34049536 |
Shunhao Zhang1, Tianle Li1, Jing Xie1, Demao Zhang1, Caixia Pi1, Lingyun Zhou2, Wenbin Yang3.
Abstract
Human milk is the gold standard for nutrition of infant growth, whose nutritional value is mainly attributed to human milk oligosaccharides (HMOs). HMOs, the third most abundant component of human milk after lactose and lipids, are complex sugars with unique structural diversity which are indigestible by the infant. Acting as prebiotics, multiple beneficial functions of HMO are believed to be exerted through interactions with the gut microbiota either directly or indirectly, such as supporting beneficial bacteria growth, anti-pathogenic effects, and modulation of intestinal epithelial cell response. Recent studies have highlighted that HMOs can boost infants health and reduce disease risk, revealing potential of HMOs in food additive and therapeutics. The present paper discusses recent research in respect to the impact of HMO on the infant gut microbiome, with emphasis on the molecular basis of mechanism underlying beneficial effects of HMOs.Entities:
Keywords: Bifidobacterium; Human milk; Human milk oligosaccharides (HMOs); Infant formula; Infant gut microbiota; Oligosaccharides (OS); Prebiotics
Year: 2021 PMID: 34049536 DOI: 10.1186/s12934-021-01599-y
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328